Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia (Q38024259)

27 August 2017

title

Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia (English)

1 reference

27 August 2017

0 references

Hiroto Miwa

1

1 reference

27 August 2017

language of work or name

1 reference

6 July 2012

1 reference

Journal of Gastroenterology

27 August 2017

published in

1 reference

27 August 2017

volume

47

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

862-871

1 reference

Functional gastroduodenal disorders

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Pathophysiology of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Current understanding of pathogenesis of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Visceral hypersensitivity in non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Prevalence of acid reflux in functional dyspepsia and its association with symptom profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Development of esophageal hypersensitivity following experimental duodenal acidification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Immunoreactive-somatostatin concentrations of the human stomach and mood state in patients with functional dyspepsia: a preliminary case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Predictors of the placebo response in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Hypnotherapy for functional gastrointestinal disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Influence of experimentally induced anxiety on gastric sensorimotor function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Food choice as a key management strategy for functional gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Relationship between symptoms and dietary patterns in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

New frontiers in gut nutrient sensor research: monosodium L-glutamate added to a high-energy, high-protein liquid diet promotes gastric emptying: a possible therapy for patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Are rice and spicy diet good for functional gastrointestinal disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Functional dyspepsia is associated with sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Exposure to severe wartime conditions in early life is associated with an increased risk of irritable bowel syndrome: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Genetic factors for functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Clinical and pathophysiological characteristics of acute-onset functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

New pathophysiological mechanisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Failed therapy and directions for the future in dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Guidelines for the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Asian consensus report on functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Therapeutic options in nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0625-9

Chronic foot-shock stress potentiates the influx of bone marrow-derived microglia into hippocampus

21 January 2018

1 reference

12 December 2020

Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study

1 reference

12 December 2020

Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia

1 reference

12 December 2020

Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin

1 reference

12 December 2020

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

12 December 2020

Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia

1 reference

12 December 2020

Gastric hypersensitivity induced by oesophageal acid infusion in healthy volunteers

1 reference

12 December 2020

Role of gastric acid in the aetiology of dyspeptic disease and dyspepsia

1 reference

12 December 2020

Functional gastroduodenal disorders

1 reference

12 December 2020

Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients

1 reference

12 December 2020

Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility.

1 reference

12 December 2020

Functional Dyspepsia: Impaired Fundic Accommodation

1 reference

12 December 2020

Role of impaired gastric accommodation to a meal in functional dyspepsia

1 reference

12 December 2020

Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial

1 reference

12 December 2020

Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography

1 reference

12 December 2020

Life style in persons with functional gastrointestinal disorders--large-scale internet survey of lifestyle in Japan

1 reference

12 December 2020

Association between early adverse life events and irritable bowel syndrome

1 reference

12 December 2020

Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidification

1 reference

12 December 2020

Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs

1 reference

12 December 2020

Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome

1 reference

12 December 2020

Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS)

1 reference

12 December 2020

Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects

1 reference

12 December 2020

Pharmacological interventions for non-ulcer dyspepsia

1 reference

12 December 2020

Psychotherapy in functional dyspepsia

1 reference

12 December 2020

Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis

1 reference

12 December 2020

Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects

1 reference

12 December 2020

Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials

1 reference

12 December 2020

Influence of abuse history on gastric sensorimotor function in functional dyspepsia

1 reference

12 December 2020

Pharmacological interventions for non-ulcer dyspepsia

1 reference

12 December 2020

10.1007/S00535-012-0625-9

Identifiers

DOI

1 reference

27 August 2017

1 reference